ENMD-2076
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for ENMD-2076, covering 2011-08-04 to 2025-04-18. Get the full timeline:
Most recent: Clinical Trial Update: A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma [Phase 2]